$CTIX Up to date company activities and other impo
Post# of 44801
![Avatar](/images/ProfileImages/516597884_9056_Emylers.jpg)
$CTIX
DD Notes ~ http://www.ddnotesmaker.com/CTIX
##### recent news/filings ~ source: finance.yahoo.com
Mon, 13 Jan 2014 12:00:00 GMT ~ Cellceutix Corporation to Present at Biotech Showcase 2014
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, today announced that the Company will be presenting ...
read full: http://finance.yahoo.com/news/cellceutix-corp...00036.html
*********************************************************
Mon, 06 Jan 2014 13:00:00 GMT ~ Cellceutix Submits Application to Institutional Review Board to Commence Clinical Trials of Anti-Psoriasis Drug Prurisol
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to announce that it has today submitted ...
read full: http://finance.yahoo.com/news/cellceutix-subm...00409.html
*********************************************************
Thu, 02 Jan 2014 20:17:03 GMT ~ Cellceutix Corp.: A Biotech With High Risk But High Reward
read full: http://wallstcheatsheet.com/stocks/cellceutix...ml/?ref=YF
*********************************************************
Fri, 20 Dec 2013 12:55:15 GMT ~ Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis With US FDA
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, announces today that it has filed an application ...
read full: http://finance.yahoo.com/news/cellceutix-file...15649.html
*********************************************************
Mon, 16 Dec 2013 14:06:06 GMT ~ Cellceutix: An Undiscovered Company Set To Rise In 2014
read full: http://seekingalpha.com/article/1900321-cellc...urce=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CTIX&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CTIX&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CTIX/company-info
Ticker: $CTIX
OTC Market Place: OTCQB
CIK code: 0001355250
Company name: Cellceutix Corp.
Company website: http://www.cellceutix.com
Incorporated In: NV, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIX/filings
Latest financials: http://www.otcmarkets.com/stock/CTIX/financials
Latest news: http://www.otcmarkets.com/stock/CTIX/news - http://finance.yahoo.com/q/h?s=CTIX+Headlines
Major holdings: http://data.cnbc.com/quotes/CTIX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIX
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Cellceutix+Corp.&a...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...eutix+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cellceutix.com
Alexa: http://www.alexa.com/siteinfo/http://www.cellceutix.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cellceutix.com
http://www.pennystocktweets.com/stocks/profile/CTIX
##### last known share structure ~ source: otcmarkets.com
Market Value: $209,828,090 a/o Jan 10, 2014
Shares Outstanding: 104,914,045 a/o Nov 04, 2013
Float: Not Available
Authorized Shares: 300,000,000 a/o May 12, 2008
Par Value: 0.0001
##### business description ~ source: otcmarkets.com
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
DD Notes ~ http://www.ddnotesmaker.com/CTIX
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)